Research Program: Prevention & Etiology
Assistant Professor, College of Pharmacy

kotly001@umn.edu
612-625-1160 — office

Research Interests

Examining: a) how various pharmocotherapies affect smoking behavior, b) the relationship between smoking and stress response, and c) the effect of psychiatric pharmacotherapy on the physiologic response to mental stress.

Selected Publications

Golding M, Kotlyar M, Carson SW, Hoyler S, Lazarus C, Davidson C, Guzzo J, Sontz E, Garbutt JC. Effects of paroxetine on cardiovascular response to mental stress in subjects with a history of coronary artery disease and no psychiatric diagnoses. Psychopharmacology 2005;182:321-6.

Kotlyar M, Brauer LH, Tracy TS, Hatsukami DK, Harris J, Bronars CA, Adson DE. Inhibition of CYP2D6 activity by bupropion. J Clin Psychopharmacol. 2005 Jun; 25(3):226-9.

Carson SW, Letrent KJ, Kotlyar M, Foose G, Tancer ME. Lack of a fluoxetine effect on prednisolone disposition and cortisol suppression. Pharmacotherapy. 2004 Apr; 24(4):482-7.

Hatsukami DK, Rennard S, Patel MK, Kotlyar M, Malcolm R, Nides MA, Dozier G, Bars MP, Jamerson BD. Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking. Am J Med. 2004 Feb 1; 116(3):151-7.

Hatsukami DK, Henningfield JE, Kotlyar M. Harm reduction approaches to reducing tobacco-related mortality. Annu Rev Public Health. 2004; 25:377-95.

Kotlyar M, Brauer LH, al'Absi M, Adson DE, Robiner W, Thuras P; Harris J, Finocchi ME; Bronars CA, Candell S, Hatsukami DK. Effect of bupropion on physiological measures of stress in smokers during nicotine withdrawal. Pharmacol Biochem Behav 2006; 83:37-79.